
| 3 min read
Patients could finally have a therapy available if the repurposed drug is successful. The trial protocol is under review with the Italian Medicines Agency.
| 4 min read
What began with a patient's search for relief from ulcerative colitis has become a biotech's effort to turn a botanical discovery into a drug.
| 2 min read
Cancer researchers have attempted to target the WNT pathway for decades without success due to severe toxicity issues. A new paper could solve that problem.
| 3 min read
Despite using identical protocols, the group of researchers showed that many oft-reported positive effects of psilocybin were not reproducible.News
Cancer Research News
Samsung Biologics' Seahee Kim explains where patient-derived organoid data earn regulatory weight and where they still fall short
A Phase 3 survival result tests whether antigen choice and disease setting explain earlier cancer vaccine setbacks
Editor's Pick
Born to differentiate and heal, mesenchymal stem cells carry great potential for treating a wide spectrum of diseases.
In a journey fraught with heartache and persistence, medical research giants paved the way for successful bone marrow transplantation.
Multimedia
From automated experiments to AI-powered analysis, connected data, and smarter resource use, digital technologies are reshaping how scientists work — and what the laboratory itself can do.
From automated experiments to AI-powered analysis, connected data, and smarter resource use, digital technologies are reshaping how scientists work — and what the laboratory itself can do.

















